Clinical Value and Mechanism Exploration of Serum miR-379 in Obesity-Polycystic Ovary Syndrome

References

• Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108–120. doi:10.1016/j.metabol.2018.11.002
   PubMed Web of Science ®Google Scholar
• Tosi F, Di Sarra D, Kaufman JM, et al. Total body fat and central fat mass independently predict insulin resistance but not hyperandrogenemia in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2015;100(2):661–669. doi:10.1210/jc.2014-2786
   PubMed Web of Science ®Google Scholar
• Shao S, Wang H, Shao W, Liu N. miR-199a-5p stimulates ovarian granulosa cell apoptosis in polycystic ovary syndrome. J Mol Endocrinol. 2020;65(4):187–201. doi:10.1530/JME-20-0077
   PubMedGoogle Scholar
• Hu M, Gao T, Du Y. MiR-98-3p regulates ovarian granulosa cell proliferation and apoptosis in polycystic ovary syndrome by targeting YY1. Med Mol Morphol. 2022;55(1):47–59. doi:10.1007/s00795-021-00307-4
   PubMed Web of Science ®Google Scholar
• Bao D, Li M, Zhou D, et al. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4. J Steroid Biochem Mol Biol. 2021;209:105844. doi:10.1016/j.jsbmb.2021.105844
   PubMed Web of Science ®Google Scholar
• Jiang X, Li J, Zhang B, et al. Differential expression profile of plasma exosomal microRNAs in women with polycystic ovary syndrome. Fertil Steril. 2021;115(3):782–792. doi:10.1016/j.fertnstert.2020.08.019
   PubMed Web of Science ®Google Scholar
• Xue Y, Lv J, Xu P, et al. Identification of microRNAs and genes associated with hyperandrogenism in the follicular fluid of women with polycystic ovary syndrome. J Cell Biochem. 2018;119(5):3913–3921. doi:10.1002/jcb.26531
   PubMed Web of Science ®Google Scholar
• Abdollahi M, Kato M, Lanting L, et al. miR-379 mediates insulin resistance and obesity through impaired angiogenesis and adipogenesis regulated by ER stress. Mol Ther Nucleic Acids. 2022;30:115–130. doi:10.1016/j.omtn.2022.09.015
   PubMedGoogle Scholar
• Fei X, Jin M, Wang Y, et al. Transcriptome reveals key microRNAs involved in fat deposition between different tail sheep breeds. PLoS One. 2022;17(3):e0264804. doi:10.1371/journal.pone.0264804
   PubMed Web of Science ®Google Scholar
• Abdollahi M, Kato M, Lanting L, Wang M, Tunduguru R, Natarajan R. Role of miR-379 in high-fat diet-induced kidney injury and dysfunction. Am J Physiol Renal Physiol. 2022;323(6):F686–F699. doi:10.1152/ajprenal.00213.2022
   PubMed Web of Science ®Google Scholar
• Cao C, Duan P, Li W, et al. Lack of miR-379/miR-544 cluster resists high-fat diet-induced obesity and prevents hepatic triglyceride accumulation in mice. Front Cell Dev Biol. 2021;9:720900. doi:10.3389/fcell.2021.720900
   PubMed Web of Science ®Google Scholar
• Franks S. Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: in defense of the Rotterdam criteria. J Clin Endocrinol Metab. 2006;91(3):786–789. doi:10.1210/jc.2005-2501
   PubMed Web of Science ®Google Scholar
• Al Wattar BH, Fisher M, Bevington L, et al. Clinical practice guidelines on the diagnosis and management of polycystic ovary syndrome: a systematic review and quality assessment study. J Clin Endocrinol Metab. 2021;106(8):2436–2446. doi:10.1210/clinem/dgab232
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhu Z, Kraft P, Deng Q, Stener-Victorin E, Jiang X. Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis. BMC Med. 2022;20(1):66. doi:10.1186/s12916-022-02238-y
   PubMed Web of Science ®Google Scholar
• Barber TM, Hanson P, Weickert MO, Franks S. Obesity and polycystic ovary syndrome: implications for pathogenesis and novel management strategies. Clin Med Insights Reprod Health. 2019;13:1179558119874042. doi:10.1177/1179558119874042
   Web of Science ®Google Scholar
• Wu L, Fang Q, Wang M, et al. Effect of weight loss on pregnancy outcomes, neuronal-reproductive-metabolic hormones and gene expression profiles in granulosa cells in obese infertile PCOS patients undergoing IVF-ET. Front Endocrinol. 2022;13:954428. doi:10.3389/fendo.2022.954428
   PubMed Web of Science ®Google Scholar
• Yang X, Wang K, Lang J, et al. Up-regulation of miR-133a-3p promotes ovary insulin resistance on granulosa cells of obese PCOS patients via inhibiting PI3K/AKT signaling. BMC Womens Health. 2022;22(1):412. doi:10.1186/s12905-022-01994-6
   PubMed Web of Science ®Google Scholar
• Yang Y, Lang P, Zhang X, et al. Molecular characterization of extracellular vesicles derived from follicular fluid of women with and without PCOS: integrating analysis of differential miRNAs and proteins reveals vital molecules involving in PCOS. J Assist Reprod Genet. 2023;40(3):537–552. doi:10.1007/s10815-023-02724-z
   PubMed Web of Science ®Google Scholar
• Prayitno GD, Lestari K, Sartika CR, et al. Potential of mesenchymal stem cells and their secretomes in decreasing inflammation markers in polycystic ovary syndrome treatment: a systematic review. Medicines (Basel). 2022;10(1). doi:10.3390/medicines10010003
   PubMedGoogle Scholar
• Xu L, Xiong F, Bai Y, et al. Circ_0043532 regulates miR-182/SGK3 axis to promote granulosa cell progression in polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19(1):167. doi:10.1186/s12958-021-00839-5
   PubMed Web of Science ®Google Scholar
• He M, Mao G, Xiang Y, et al. MicroRNA-664a-3p inhibits the proliferation of ovarian granulosa cells in polycystic ovary syndrome and promotes apoptosis by targeting BCL2A1. Ann Transl Med. 2021;9(10):852. doi:10.21037/atm-21-1614
   PubMed Web of Science ®Google Scholar
• Yuanyuan Z, Zeqin W, Xiaojie S, Liping L, Yun X, Jieqiong Z. Proliferation of ovarian granulosa cells in polycystic ovarian syndrome is regulated by MicroRNA-24 by targeting Wingless-Type Family Member 2B (WNT2B). Med Sci Monit. 2019;25:4553–4559. doi:10.12659/MSM.915320
   PubMed Web of Science ®Google Scholar
• Kato M, Abdollahi M, Tunduguru R, et al. miR-379 deletion ameliorates features of diabetic kidney disease by enhancing adaptive mitophagy via FIS1. Commun Biol. 2021;4(1):30. doi:10.1038/s42003-020-01516-w
   PubMed Web of Science ®Google Scholar
• de Guia RM, Rose AJ, Sommerfeld A, et al. microRNA-379 couples glucocorticoid hormones to dysfunctional lipid homeostasis. EMBO J. 2015;34(3):344–360. doi:10.15252/embj.201490464
   PubMed Web of Science ®Google Scholar
• Zhang H, Wang W, Zhao J, et al. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Front Endocrinol. 2022;13:1085656. doi:10.3389/fendo.2022.1085656
   PubMed Web of Science ®Google Scholar
• van der Klaauw AA, Croizier S, Mendes de Oliveira E, et al. Human semaphorin 3 variants link melanocortin circuit development and energy balance. Cell. 2019;176(4):729–42 e18. doi:10.1016/j.cell.2018.12.009
   PubMed Web of Science ®Google Scholar
• Hayashi M, Nakashima T, Yoshimura N, Okamoto K, Tanaka S, Takayanagi H. Autoregulation of osteocyte Sema3A orchestrates estrogen action and counteracts bone aging. Cell Metab. 2019;29(3):627–37 e5. doi:10.1016/j.cmet.2018.12.021
   PubMed Web of Science ®Google Scholar
• Li M, Gao X, Liu K, Bao N, Jiang Z. MiR-379-5p aggravates experimental autoimmune uveitis in mice via the regulation of SEMA3A. Autoimmunity. 2021;54(5):275–283. doi:10.1080/08916934.2021.1931841
   PubMed Web of Science ®Google Scholar
• Zhong Z, Li F, Li Y, et al. Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome. Mol Med Rep. 2018;17(4):4889–4898. doi:10.3892/mmr.2018.8463
   PubMed Web of Science ®Google Scholar
• Deng J, Li C, Luo J, Xie J, Peng C, Deng X. MicroRNA-125b controls growth of ovarian granulosa cells in polycystic ovarian syndrome by modulating cyclin B1 expression. Arch Med Sci. 2022;18(3):746–752. doi:10.5114/aoms.2019.85809
   PubMed Web of Science ®Google Scholar